News Releases

- V-VET1, a clinical-stage animal health-specific product candidate, is a vaccinia viral strain which selectively replicates in cancer cells causing cell death (apoptosis) - Terms of the agreement grant ELIAS the worldwide right to development and commercialization of V-VET1 for the diagnosis,
November 18, 2021
Displaying 1 - 10 of 11